UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000042892
Receipt No. R000048960
Scientific Title Efficacy and safety of irinotecan after chemotherapy in combination with immunotherapy in patients with extensive stage small cell lung cancer: a phase II trial
Date of disclosure of the study information 2021/01/05
Last modified on 2021/01/05 16:31:27

No. Disposal Last modified on Item of update
1 Insert 2021/01/04 11:01:50
2 Update 2021/01/05 16:26:17 Date of disclosure of the study information
3 Update 2021/01/05 16:27:05 Recruitment status
Date of IRB
Anticipated trial start date
4 Update 2021/01/05 16:30:06 Recruitment status
5 Update 2021/01/05 16:30:48 Recruitment status
6 Update 2021/01/05 16:31:27 Recruitment status
Anticipated trial start date

Contact us.